Wanda K. Jones

2.5k total citations · 1 hit paper
29 papers, 1.8k citations indexed

About

Wanda K. Jones is a scholar working on Surgery, Oncology and General Health Professions. According to data from OpenAlex, Wanda K. Jones has authored 29 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 8 papers in Oncology and 7 papers in General Health Professions. Recurrent topics in Wanda K. Jones's work include Ovarian cancer diagnosis and treatment (7 papers), Intraperitoneal and Appendiceal Malignancies (6 papers) and Cancer Treatment and Pharmacology (6 papers). Wanda K. Jones is often cited by papers focused on Ovarian cancer diagnosis and treatment (7 papers), Intraperitoneal and Appendiceal Malignancies (6 papers) and Cancer Treatment and Pharmacology (6 papers). Wanda K. Jones collaborates with scholars based in United States, New Zealand and Italy. Wanda K. Jones's co-authors include Thomas B. Hakes, Stephen C. Rubin, Bonnie Reichman, Maurie Markman, William J. Hoskins, Lois Almadrones, John L. Lewis, Robert Rothman, William J. Kassler and Charles Haley and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Clinical Microbiology and Emerging infectious diseases.

In The Last Decade

Wanda K. Jones

29 papers receiving 1.7k citations

Hit Papers

Second-line platinum ther... 1991 2026 2002 2014 1991 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin.
    1991 647 citations Maurie Markman, Robert Rothman et al. Journal of Clinical Oncology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Wanda K. Jones 1.1k 856 464 280 247 29 1.8k
Luigi Frigerio 827 0.8× 582 0.7× 289 0.6× 961 3.4× 111 0.4× 88 2.2k
Sunesh Kumar 1.0k 0.9× 1.2k 1.5× 283 0.6× 1.5k 5.5× 164 0.7× 217 3.3k
D. Raudrant 275 0.3× 219 0.3× 134 0.3× 387 1.4× 45 0.2× 99 1.5k
Jay W. Carlson 1.0k 0.9× 957 1.1× 677 1.5× 1.1k 3.8× 55 0.2× 67 3.0k
John Boyce 295 0.3× 451 0.5× 343 0.7× 675 2.4× 38 0.2× 49 1.6k
Alexandros Rodolakis 1.3k 1.2× 806 0.9× 735 1.6× 1.6k 5.9× 42 0.2× 253 3.4k
Yin Ling Woo 185 0.2× 221 0.3× 388 0.8× 208 0.7× 76 0.3× 58 1.3k
Mitchell Maiman 1.9k 1.7× 1.8k 2.1× 1.0k 2.2× 3.4k 12.2× 205 0.8× 56 5.2k
Risto Aine 334 0.3× 435 0.5× 307 0.7× 113 0.4× 30 0.1× 73 1.6k
Frances Wong 461 0.4× 455 0.5× 842 1.8× 603 2.2× 25 0.1× 52 2.4k

Countries citing papers authored by Wanda K. Jones

Since Specialization
Citations

This map shows the geographic impact of Wanda K. Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanda K. Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanda K. Jones more than expected).

Fields of papers citing papers by Wanda K. Jones

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wanda K. Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanda K. Jones. The network helps show where Wanda K. Jones may publish in the future.

Co-authorship network of co-authors of Wanda K. Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Wanda K. Jones. A scholar is included among the top collaborators of Wanda K. Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wanda K. Jones. Wanda K. Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jones, Wanda K., Robert A. Hahn, R. Gibson Parrish, Steven M. Teutsch, & Man‐Huei Chang. (2019). Male Mortality Trends in the United States, 1900-2010: Progress, Challenges, and Opportunities. Public Health Reports. 135(1). 150–160. 1 indexed citations
2.
Koh, Howard K., et al.. (2014). Toward an Integrated Public Health Approach for Epilepsy in the 21st Century. Preventing Chronic Disease. 11. E146–E146. 25 indexed citations
3.
Dickson, Geri L., et al.. (2005). Strategic State-level Nursing Workforce Initiatives. Nursing Administration Quarterly. 29(2). 162–170. 4 indexed citations
4.
Jones, Wanda K.. (2004). Men's health as a public health issue. The Journal of Men s Health and Gender. 1(2-3). 147–149. 1 indexed citations
5.
Harvey, et al.. (2003). The Auckland Breast Cancer Register: a special project of the Auckland Breast Cancer Study Group.. PubMed. 116(1184). U648–U648. 12 indexed citations
6.
Jones, Wanda K.. (2000). . Women s Health Issues. 10(2). 86–89. 1 indexed citations
7.
Scaloni, Andrea, Paolo Ingallinella, Annapaola Andolfo, et al.. (1999). Structural Investigations on Human Erythrocyte Acylpeptide Hydrolase by Mass Spectrometric Procedures. Journal of Protein Chemistry. 18(3). 349–360. 8 indexed citations
8.
Kassler, William J., Beth Dillon, Charles Haley, Wanda K. Jones, & Anne Goldman. (1997). On-site, rapid HIV testing with same-day results and counseling. AIDS. 11(8). 1045–1051. 139 indexed citations
9.
Harris, Jeffrey R., et al.. (1997). Managed care--issues and opportunities: a view from the CDC.. PubMed. 52(2). 85–8. 3 indexed citations
10.
Farnham, Paul G., Robin D. Gorsky, David R. Holtgräve, & Wanda K. Jones. (1996). Blood pressure and body measurements among Navajo adolescents.. PubMed. 111(1). 44–53; discussion 54. 71 indexed citations
11.
Markman, Maurie, Bonnie Reichman, Thomas B. Hakes, et al.. (1992). Impact on survival of surgically defined favorable responses to salvage intraperitoneal chemotherapy in small-volume residual ovarian cancer.. Journal of Clinical Oncology. 10(9). 1479–1484. 63 indexed citations
12.
Markman, M, Thomas B. Hakes, Bonnie Reichman, et al.. (1992). Ifosfamide and mesna in previously treated advanced epithelial ovarian cancer: activity in platinum-resistant disease.. Journal of Clinical Oncology. 10(2). 243–248. 108 indexed citations
13.
Markman, Maurie, Eric K. Rowinsky, Thomas B. Hakes, et al.. (1992). Phase I trial of intraperitoneal taxol: a Gynecoloic Oncology Group study.. Journal of Clinical Oncology. 10(9). 1485–1491. 240 indexed citations
14.
Markman, Maurie, Bonnie Reichman, Thomas B. Hakes, et al.. (1991). Responses to second-line cisplatin-based intraperitoneal therapy in ovarian cancer: influence of a prior response to intravenous cisplatin.. Journal of Clinical Oncology. 9(10). 1801–1805. 143 indexed citations
15.
Markman, Maurie, Robert Rothman, Thomas B. Hakes, et al.. (1991). Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin.. Journal of Clinical Oncology. 9(3). 389–393. 647 indexed citations breakdown →
16.
Markman, Maurie, Thomas B. Hakes, Bonnie Reichman, et al.. (1991). Phase II trial of weekly or biweekly intraperitoneal mitoxantrone in epithelial ovarian cancer.. Journal of Clinical Oncology. 9(6). 978–982. 27 indexed citations
17.
Markman, Maurie, Thomas B. Hakes, Bonnie Reichman, et al.. (1991). Intraperitoneal cisplatin and cytarabine in the treatment of refractory or recurrent ovarian carcinoma.. Journal of Clinical Oncology. 9(2). 204–210. 33 indexed citations
18.
Markman, Maurie, George M. Varghese, Thomas B. Hakes, et al.. (1990). Phase II trial of intraperitoneal mitoxantrone in the management of refractory ovarian cancer.. Journal of Clinical Oncology. 8(1). 146–150. 58 indexed citations
19.
Reichman, Bonnie, Maurie Markman, Thomas B. Hakes, et al.. (1989). Intraperitoneal cisplatin and etoposide in the treatment of refractory/recurrent ovarian carcinoma.. Journal of Clinical Oncology. 7(9). 1327–1332. 68 indexed citations
20.
Hannon, W. Harry, et al.. (1989). A Quality Assurance Program for Human Immunodeficiency Virus Seropositivity Screening of Dried-Blood Spot Specimens. Infection Control. 10(1). 8–13. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luigi Frigerio Breakdown of academic impact, for papers by Sunesh Kumar Breakdown of academic impact, for papers by D. Raudrant Breakdown of academic impact, for papers by Jay W. Carlson Breakdown of academic impact, for papers by John Boyce Breakdown of academic impact, for papers by Alexandros Rodolakis Breakdown of academic impact, for papers by Yin Ling Woo Breakdown of academic impact, for papers by Mitchell Maiman Breakdown of academic impact, for papers by Risto Aine Breakdown of academic impact, for papers by Frances Wong
Rankless by CCL
2026